AstraZeneca Other Operating Income or Expenses 2010-2024 | AZN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AstraZeneca annual other operating income or expenses for 2023 were $1.34B, a 160.7% increase from 2022.
AstraZeneca annual other operating income or expenses for 2022 were $0.514B, a 65.55% decline from 2021.
AstraZeneca annual other operating income or expenses for 2021 were $1.492B, a 2.36% decline from 2020.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AstraZeneca annual other operating income or expenses for 2023 were $1.34B, a 160.7% increase from 2022.
AstraZeneca annual other operating income or expenses for 2022 were $0.514B, a 65.55% decline from 2021.
AstraZeneca annual other operating income or expenses for 2021 were $1.492B, a 2.36% decline from 2020.